Skip to main content
Equibles

MORGAN STANLEY

Position in DYAI — Dyadic International Inc

CIK 895421 NEW YORK, NY
Back to DYAI Full portfolio

Position in DYAI

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$240
+$54 QoQ
Shares Held
268
+18.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 39 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 12% Shared 0% None 88%

Common Shares in DYAI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. DYAI ranks #486 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in DYAI

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $240 268
2026-03-31 $186 227
2025-12-31 $213 227
2025-09-30 $6,403 5,427
2025-06-30 $5,597 5,654
2025-03-31 $7,632 5,654
2024-12-31 $9,894 5,654
2024-09-30 $12,744 12,254
2024-06-30 $671 454
2024-03-31 $758 454
2023-12-31 $730 454
2023-09-30 $871 454
2023-06-30 $10,526 5,454
2023-03-31 $9,708 5,454
2022-12-31 $6,735 5,476
2022-09-30 $12,416 6,501
2022-06-30 $19,684 6,454
2022-03-31 $37,615 12,497
2021-12-31 $32,534 7,198
2021-09-30 $40,214 7,233
2021-06-30 $50,226 13,991
2021-03-31 $6,060 1,104
2020-12-31 $132,912 24,705
2020-09-30 $75,472 9,970
2020-06-30 $51,587 5,957
2020-03-31 $45,661 8,781